EP Patent

EP4098302A1 — Breath actuated inhaler

Assigned to Norton Waterford Ltd · Expires 2022-12-07 · 3y expired

What this patent protects

A metered dose inhaler and in particular, a breath actuated metered dose inhaler, providing a valve port (1095) and a diaphragm (1000) for a pneumatic force holding unit of a breath actuated metered dose inhaler, a flap valve (36) for the canister fire system of a breath actuated…

USPTO Abstract

A metered dose inhaler and in particular, a breath actuated metered dose inhaler, providing a valve port (1095) and a diaphragm (1000) for a pneumatic force holding unit of a breath actuated metered dose inhaler, a flap valve (36) for the canister fire system of a breath actuated metered dose inhaler, as well as methods for manufacturing and assembling the same. The valve port further comprises an annular boss (1100) with an inner wall defining a valve orifice channel (78), wherein the volume of the orifice channel defined by the inner wall of the boss is greater than about 12.7 % of the volume of the boss and/or wherein then inner wall defines a frustum of an imaginary cone with an apex angle of greater than about 20 degrees, preferably from about 22 degrees to about 35 degrees.

Drugs covered by this patent

Patent Metadata

Patent number
EP4098302A1
Jurisdiction
EP
Classification
Expires
2022-12-07
Drug substance claim
No
Drug product claim
No
Assignee
Norton Waterford Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.